Status:

UNKNOWN

Phase I Single-dose Escalation Clinical Trial of Salvianolic Acid A Tablets

Lead Sponsor:

Peking University First Hospital

Collaborating Sponsors:

Shandong Huizhi Pharmaceutical Technology Co., Ltd.

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Conditions:

Neuropathy of Diabetes

Eligibility:

All Genders

18-45 years

Phase:

PHASE1

Brief Summary

Salvianolic acid A has a variety of pharmacological effects, such as: anti-oxidation, scavenging oxygen free radicals, anti-fibrosis, anti-myocardial ischemia, anti-coagulation, anti-thrombosis, anti-...

Eligibility Criteria

Inclusion

  • 1\) Gender: male or female, healthy volunteers; 2) Age: 18\~45 years old; 3) Weight: Male subjects need to weigh ≥ 50kg, female subjects should have ≥ 45kg, body mass index \[BMI = weight (kg) / height 2 (m2)\] in the range of 19 \~ 25 kg / m2; 4) Subjects must give informed consent to the trial prior to the trial and voluntarily sign a written informed consent form; 5) The subject is able to communicate well with the investigator and is able to complete the trial in accordance with the protocol.

Exclusion

  • (1) Hepatitis B surface antigen, hepatitis C virus, human immunodeficiency virus and syphilis positive; (2) alcoholics; (3) subjects who took any drug or long-term use of drugs within 2 weeks before screening (4) Blood donors within 3 months prior to the trial; (5) participated in any drug clinical trial within 3 months prior to screening; (6) had a clear history of allergic disease; (7) had central nervous system, cardiovascular Systematic, kidney, liver, digestive tract, lung disease, metabolic and skeletal muscle system with a clear history or other significant disease; (8) pregnant, lactating women; (9) other factors not suitable for participation in the study.

Key Trial Info

Start Date :

November 20 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 20 2019

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT03791125

Start Date

November 20 2018

End Date

May 20 2019

Last Update

January 2 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Pharmacy, Base for Clinical Trial, Peking University First Hospital

Beijing, Beijing Municipality, China, 100034

Phase I Single-dose Escalation Clinical Trial of Salvianolic Acid A Tablets | DecenTrialz